AR and neoplasm: Since TAMs, macrophages that have been educated by the tumor cells and assist in cancer progression have been implicated in causing resistance to tamoxifen in breast cancer and to androgen receptor antagonists in prostate cancer; a potential future therapeutic strategy could be to reeducate TAMs to express an antitumor phenotype that would work against the tumor instead of with it [79, 80, 83, 84].